Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Citi has put a buy rating on a biotech giant due to strong immunoglobulin demand, particularly for CIDP treatment.
  • Bell Potter has upgraded an online retailer to a buy rating, anticipating favourable trading updates and market share growth.
  • Morgans has upgraded an energy company to a buy rating, citing strong quarterly performance and strategic partnership benefits.

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Excited couple celebrating success while looking at smartphone.

Image source: Getty Images

CSL Ltd (ASX: CSL)

According to a note out of Citi, its analysts have retained their buy rating and $265.00 price target on this biotechnology giant's shares. The broker has been looking into immunoglobulin demand and highlights that it remains strong. It has surveyed neurologists in the United States and found that they are continuing to use it to treat autoimmune neurological disorder CIDP. Given how this makes up almost a quarter of its immunoglobulin sales, Citi thinks this is good news. As a result, it continues to see value in its shares at current levels and is recommending them to clients. The CSL share price is trading at $214.33 this afternoon.

Temple & Webster Group Ltd (ASX: TPW)

A note out of Bell Potter reveals that its analysts have upgraded this online furniture and homewares retailer's shares to a buy rating with a $28.00 price target. The broker is feeling confident ahead of the release of a trading update from Temple & Webster next month. It is expecting the company to benefit from softer comps in the months of September and October and be tracking close to consensus estimates for the first half. Outside this, the broker continues to see catalysts of outperformance as market share capture in an expanded total addressable market is expedited with range, pricing/scale advantages, backed by a strong balance sheet. And with its shares pulling back meaningfully in recent weeks, it thinks now is the time to invest. The Temple & Webster share price is fetching $25.12 at the time of writing.

Woodside Energy Group Ltd (ASX: WDS)

Analysts at Morgans have upgraded this energy giant's shares to a buy rating with a $30.50 price target. According to the note, the broker was pleased with the company's performance in the third quarter, noting that it was a strong operational and sales result. Another positive is the entry of US midstream player Williams into the Louisiana joint venture. Morgans believes that Willams will help de-risk infrastructure and feed gas delivery. Combined with good macro news, the broker isn't surprised that Woodside shares are gaining support with investors. The Woodside share price is trading at $24.30 on Friday.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in CSL, Temple & Webster Group, and Woodside Energy Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Temple & Webster Group. The Motley Fool Australia has recommended CSL and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Macquarie says this Gina Rinehart-backed miner could pile on more than 150% in value

A big jump in rare earths resources has the analysts interested.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Broker Notes

Data centre work could help drive this ASX industrial stock to a record high

This company has a track record of strong growth.

Read more »

A view of competitors in a running event, some wearing number bibs, line up together on a starting line looking ahead as if to start a race.
Broker Notes

Buy, hold, sell: Sonic Healthcare, AMP, CBA shares

Let's start the week with some fresh ratings from the experts. 

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Group of people toasting with wine
Broker Notes

Buy, hold, sell: Transurban, Orora, Treasury Wine Estates shares

Here's what top broker Morgans thinks of these 3 ASX 200 shares following their FY26 reports.

Read more »

Businessman studying a high technology holographic stock market chart.
Broker Notes

8 ASX 200 shares with fresh buy ratings this week

Brokers retained a positive view on Westpac, Sonic Healthcare, Minerals 260, and other shares.

Read more »

Woman working on her laptop at a café.
Broker Notes

7 ASX 200 shares downgraded by the experts this week

Brokers reduced their ratings on IAG, Seek, Woolworths, and other ASX 200 stocks.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans names 3 ASX shares to buy

The broker has good things to say about these shares. Here's what you need to know.

Read more »